香港尊龙凯时·(中国区)人生就是搏!国际药业有限公司是一家跨国际领先水平的高科技型企业
，公司总部位于中国香港九龙区
。拥有雄厚的经济实力
、先进的生产设备
、优秀的科研开发队伍及其高素质的市场管理人员
，公司主营高尖端生物制剂
、原装进口生物制剂
；是一家著名的投资与生物技术研发机构
，主要涉及生物工程
、医学
、农业三大领域
，公司于2009年进入大陆（上海总办事处）
，在国内上海
、厦门
、郑州
、北京均设有营销中心和生产基地
。
香港尊龙凯时·(中国区)人生就是搏!国际药业有限公司主要从事高尖端生物制品的研发
、生产和销售等工作
。公司对于高科技新产品的研发始终放在首位
，公司采用先进的高效液相紫外分析检测仪器
、靶向技术
，为产品进行全程质量监控
，确保稳定高效的产品质量
。目前公司已经根据中国养殖业的发展需要开发了多款新产品
，如血清抗体
，卵黄抗体
，刀豆素
、胸腺肽
，干扰素
，进口cc肽
，克罗因子等高科技无残留生物制品
。对猪
、牛
、羊
、鸡
、鸭
、鹅
、飞禽
、宠物以及特种动物等高致命性疾病具有很强的控制能力
。得到了业内的广泛认可
。在全国20多个省
、市
、自治区形成覆盖广
、功能强的营销网络
。
Hong Kong xin international pharmaceutical co., LTD. Is an international leading level of high science and technology enterprises, the company is headquartered in Hong Kong, China, Kowloon. With strong economic strength, advanced production equipment, excellent research and development team and high quality market management personnel, the company's main sophisticated biological agents, imported from biological preparation; Is a famous investment and biotechnology research and development institutions, mainly involves three areas, biological engineering, medicine, agriculture company (Shanghai office) in 2009 into the mainland, in the domestic Shanghai, xiamen, zhengzhou, Beijing has marketing center and production base.
Hong Kong xin international pharmaceutical co., LTD is mainly engaged in cutting-edge research and development, production and sales of biological products. Company to high-tech research and development of new products always in the first place, the company USES the advanced detection instruments, targeting technology, uv and HPLC analysis for product quality monitoring, to ensure stable and efficient product quality. At present, the company has according to the needs of the development of China's aquaculture has developed many new products, such as serum antibody, yolk antibody, sword bean element, uct, interferon, import cc peptide, crow factor is no residual on high-tech biological products. For pigs, cattle, sheep, chickens, ducks, geese, birds, pets and special animal such as a deadly disease has a strong control ability. The industry wide recognition. Across the country more than 20 provinces, municipalities and autonomous regions to form function of wide coverage, strong marketing network.
|
